Considered and approved quarterly financial result for the period ended 31.12.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Choksi Laboratories reported Q3 FY26 revenue from operations of Rs 1,082.47 lakhs, up about 4% from Rs 1,038.42 lakhs in Q3 FY25. Total income for the quarter stood at Rs 1,095.81 lakhs vs Rs 1,039.26 lakhs. For the 9-month period, revenue rose to Rs 3,318.37 lakhs from Rs 3,038.28 lakhs (~9% growth). The company booked an exceptional gain of Rs 77.80 lakhs from the sale of an office flat, which boosted reported pre-tax profit to Rs 90.38 lakhs and net profit to Rs 93.75 lakhs for the quarter, against Rs 18.24 lakhs and Rs 24.83 lakhs respectively a year ago. Excluding the exceptional item, profit before tax was lower at Rs 12.58 lakhs versus Rs 18.24 lakhs in Q3 FY25, indicating underlying pressure on margins. EPS for the quarter was Rs 0.45 vs Rs 0.35. Statutory auditor Prateek Jain & Co. issued an unqualified limited review report with no qualifications.
Headline profit jump looks impressive but is largely driven by a one-time gain from selling an office flat; core operating profitability actually dipped in Q3. Investors should watch for sustained revenue growth and improvement in operating margins in coming quarters before drawing positive conclusions on the business trajectory.